Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Clinical and Translational Oncology – incl. option to publish open access (Editorial Board)

Clinical and Translational Oncology

Clinical and Translational Oncology

Editor-in-Chief: Pere Gascon

ISSN: 1699-048X (print version)
ISSN: 1699-3055 (electronic version)

Journal no. 12094

Clinical Oncology
Andrés Cervantes
Servicio de Hematologia Medica y Oncologia Medica
Hospital Clinico Universitario
Avda. Blasco Ibanez 17
46010 Valencia, Spain

Translational Oncology
Rosario Perona
Instituto de Investigaciones Biomédicas
C/ Arturo Duperier, 4
28029 Madrid, Spain

Juan Carlos Lacal
Instituto de Investigaciones Biomédicas
C/ Arturo Duperier, 4
28029 Madrid, Spain


María Blasco (Madrid, Spain)
Hans Bos (Utrech, Holland)
Julio Celis (Copenhagen, Denmark)
Manel Esteller (Madrid, Spain)
Michael Karin (San Diego, USA)
Carlos López Otín (Oviedo, Spain)
Joan Massagué (New York, USA)
Ángel Pellicer (New York, USA)
Manuel Perucho (California, USA)
Eric Rowinsky (New York, USA)
Paul Workman (London, UK)

Juan Pablo Albar (Madrid, Spain)
Félix Bonilla (Madrid, Spain)
Jesús García Foncillas (Pamplona, Spain)

Jaffer Ajani (Houston, USA)
Jean Pierre Armand (Villejuif, France)
Josep Baselga (Barcelona, Spain)
Alfredo Carrato (Elche, Spain)
Ramón Colomer (Girona, Spain)
Hernán Cortés Funes (Madrid, Spain)
Eduardo Díaz-Rubio (Madrid, Spain)
Gabriel Hortobagyi (Houston, USA)
Thierry Le Chevalier (Villejuif, France)
Roman Perez Soler (New York, USA)
Rafael Rosell (Badalona, Spain)

Elías Campo (Barcelona, Spain)
Carlos Cordón-Cardó (New York, USA)
Manuel Nistal (Madrid, Spain)
Miguel Ángel Piris (Madrid, Spain)

Victoria Castel Sánchez (Valencia, Spain)
Carlos Rodríguez Galindo (Memphis, USA)
José Sanchez de Toledo (Barcelona, Spain)
Michel Stevens (Bristol, England)

Leoncio Arribas (Valencia, Spain)
Jacques Bernier (Bellinzona, Switzerland)
Jean Bourhis (Villejuif, France)
Felipe Calvo (Madrid, Spain)
Higinia Cárdenes (Indianápolis, USA)
Laura Cerezo (Madrid, Spain)
Jordi Giralt (Barcelona, Spain)
Alvaro Martinez (Detroit, USA)
Pedro Prada (Oviedo, Spain)
José Mariano Ruiz de Almodóvar (Granada, Spain)
Salva Villá (Barcelona, Spain)

Joaquín Dopazo (Valencia, Spain)
Javier Sánchez (Madrid, Spain)
Alfonso Valencia (Madrid, Spain)

Miguel Ángel Cuesta Valentín (Amsterdam, Holland)
Dominique Elias (Villejuif, France)
Joan Figueras (Girona, Spain)
Enrique Moreno González (Madrid, Spain)
Mitsuru Sasako (Tokyo, Japan)
Paul Sugarbaker (Washington DC, USA)



For authors and editors

  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 1.600
  • Aims and Scope

    Aims and Scope


    Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Conflict of Interest Form (pdf, 1.1 MB)
  • Author Academy: Training for Authors
  • Copyright information

    Copyright information


    Copyright Information 

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Federación de Sociedades Españolas de Oncología (FESEO) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Federación de Sociedades Españolas de Oncología (FESEO) effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author’s accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”.

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at springerlink.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via www.springerlink.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from Federación de Sociedades Españolas de Oncología (FESEO). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center’s RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on SpringerLink.com or on SpringerImages.com and click on the permissions link or go to copyright.com and enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Federación de Sociedades Españolas de Oncología (FESEO)

Alerts for this journal


Get the table of contents of every new issue published in Clinical and Translational Oncology.